NCT06950177 - Pancoronavirus Vaccine Study in Healthy Adults | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 8, 2025

Primary Completion Date

August 30, 2026

Study Completion Date

August 30, 2026

Conditions

COVID-19 Respiratory InfectionSARS CoV 2 InfectionCOVID-19 Vaccine

Interventions

BIOLOGICAL

CoV-RBD-scNP-001 and 3M-052-AF

All subjects will receive the investigational vaccine CoV-RBD-scNP-001 adjuvanted with 3M-052-AF.

Trial Locations (1)

RECRUITING

Duke University Health System, Durham